4D modeling in a gimbaled linear accelerator by using gold anchor markers.

Clinical precision in radiation therapy often relies on tracking moving targets during treatment. No prior work had resolved the specific performance limits of certain metallic fiducials within advanced tracking platforms. That uncertainty drove the need to assess how marker geometry influences signal acquisition. Prior research has shown that respiratory motion complicates accurate dose delivery to thoracic malignancies. This gap motivated an evaluation of tracking reliability under varying anatomical densities. It was already known that image quality degrades as tissue depth increases during X-ray procedures. That limitation necessitated a systematic investigation into how marker dimensions affect software modeling capabilities. Researchers sought to define the operational boundaries for these specific gold implants in a clinical setting.

The aim of this study was to verify the performance of dynamic tumor tracking using specific gold implants in a gimbaled linear accelerator. Researchers sought to determine if these markers could reliably guide the Vero4DRT system during simulated breathing. The investigation addressed whether marker geometry influences the feasibility of 4D modeling across varying tissue thicknesses. This work was motivated by the need to optimize motion management for patients undergoing thoracic radiation. The team examined how different imaging voltages affect the detectability of these metallic fiducials. They aimed to identify the operational limits of the tracking software when challenged by increased water equivalent path lengths. By simulating organ motion, the researchers intended to establish clear guidelines for clinical implementation. This study provides necessary data to support the use of these markers in specific anatomical sites.

Review Approach involved simulating respiratory motion using a programmable table with a 30 mm amplitude and 3 s cycle. Investigators placed metallic fiducials inside a Tough Water phantom to mimic clinical conditions. The team adjusted phantom thickness at 2 cm intervals to test various tissue depths. Imaging utilized 80 kV and 125 kV settings with consistent current and exposure time parameters. Researchers compared short and long marker configurations to evaluate detection consistency. The analysis defined the modeling threshold based on the minimum detectable signal error. This systematic assessment allowed for the determination of operational limits across different imaging voltages. The methodology focused on establishing the feasibility of tracking within a specific gimbaled linear accelerator environment.

Key Findings From the Literature indicate that the system successfully performs 4D modeling under most tested conditions. The researchers identified that the modeling limitation occurs at 6 cm thickness for 80 kV and 10 cm for 125 kV. A loss in detectability of approximately 6% was observed when using a 2 cm phantom thickness at 125 kV. The data demonstrate that both short and long marker types provide sufficient signal for tracking in shallow depths. Tracking capabilities remain stable except when exceeding the defined thickness thresholds for each voltage. The study confirms that these specific gold implants are compatible with the Vero4DRT system. Results highlight that imaging voltage directly impacts the maximum depth for reliable marker identification. The findings establish a clear operational range for implementing this tracking technology in clinical practice.

Synthesis and Implications suggest that the tested gold implants are viable for dynamic tracking in shallow anatomical regions. Authors propose that these markers support effective motion management for lung cancer patients. The investigation indicates that imaging voltage influences the maximum depth at which tracking remains reliable. Researchers note that modeling errors occur infrequently when the tissue equivalent path remains minimal. The study clarifies that marker length configurations do not prevent successful system integration for appropriate candidates. Evidence supports the use of this technology when the water equivalent path length is sufficiently low. The findings provide a framework for selecting optimal imaging parameters based on patient body habitus. Future clinical applications should account for the identified thickness thresholds to maintain tracking accuracy.